Alkermes plc (ALKS)

Kezar (KZR) Doubles on Promising Kidney Disorder Study Data

Shares of Kezar (KZR) surge more than 100% during after-hour trading on Jun 27, following a promising data readout from a mid-stage study evaluating zetomipzomib in patients with active lupus nephritis.

IBD Screen Of The Day: Global Leaders Highlight These Top Health Care Stocks

GSK announced positive results in a late-stage study on a new Covid-19 vaccine targeted to combat the omicron variant.

• 
  Warren Buffett Stocks: META, GOOGL Among 25 Names On This Screen

  Investor's Business Daily
• 
  IBD Screen Of The Day: Analysts Expect Favorable Profits From These 3 Stocks

  Investor's Business Daily

Gilead (GILD) HIV Candidate Gets Positive CHMP Recommendation

Gileads (GILD) lenacapavir gets a positive CHMP opinion for the treatment of HIV-1 infection.